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ABSTRACT
Focal infection theory proposed in early 1900’s stated that dental infection caused systemic disorders. Nevertheless, 
the theory was abandoned since large number of teeth were extracted with no satisfying result. Recent reports 
revealed that oral infections were able to spread systemically. However, there is no rationalization available to 
explain how assisted drainage therapy (ADT), a periodontal therapy that could relief migraine and asthma within 
minutes. Oral neurogenic and immunogenic inflammation interaction involving pro-inflammatory markers such 
as calcitonin gene-related peptide (CGRP), TNF-α; and antiinflammatory vasoactive intestinal peptide (VIP) was 
still under investigation. Objective: To verify the spread of oral inflammation to distant organ after performing 
ADT by analysing CGRP, VIP and TNF-α expressions. Methods: Two different concentration of Porphyromonas 
gingivalis lipopolysaccharide (PgLPS1435/1450) was injected intragingivally into two groups of 12 Wistar rats. 
After four days, 12 rats were given ADT and all samples were subsequently sacrificed 40 mins after ADT. 
Immunohistochemistry analysis using CGRP, VIP and TNF-α on the nasal and bronchus tissue was performed. 
ANOVA was used for statistical analyisis of the difference between CGRP, VIP and TNF-α expression between 
experimental groups. Results: PgLPS injections slightly increased CGRP, VIP and TNF-α expressions in the control 
group. Rats undergone ADT had lower CGRP and TNF-α but higher VIP expressions. Conclusion: Neurogenic 
inflammation involved in systemic spread of oral infection. ADT was able to downregulate inflammation in distant 
organ posibly by stimulating VIP.
ABSTRAK
Inflammasi neurogenik berperan pada penyebaran infeksi oral. Teori infeksi fokal rongga mulut telah diusulkan 
sejak awal 1900an, infeksi gigi menyebabkan berbagai penyakit sistemik. Namun, teori ini mulai ditinggalkan 
setelah banyak gigi telah dicabut tanpa memberikan hasil yang memuaskan. Penelitian terbaru membuktikan 
bahwa infeksi rongga mulut dapat menyebar secara sistemik. Walaupun demikian, penemuan terdahulu tidak dapat 
membuktikan bagaimana terapi periodontal “assisted drainage” (ADT), dapat mengurangi gejala migren dan asma 
dalam hitungan menit. Penelitian terkait interaksi keradangan imunogenik dan neurogenik yaitu mediator pro-
inflamasi calcitonin gene-related peptide (CGRP), TNF-α dan vasoactive intestinal peptide (VIP) masih jarang 
dilakukan. Tujuan: Melakukan verifikasi penyebaran keradangan neurogenik mulut ke organ yang jauh setelah 
melakukan ADT melalui ekspresi CGRP, VIP dan TNF-α. Metode: 24 tikus wistar jantan disuntik intragingival 
dengan lipopolisakarida Porphyromonas gingivalis (PgLPS1435/1450). Setelah empat hari, 12 tikus diberikan ADT, 
kemudian semua sampel dikorbankan 40 menit setelah ADT. Ekpresi CGRP, VIP dan TNF-α dianalisis dengan 
imunohistokimia. Analisis statistik menggunakan ANOVA dilakukan untuk menganalisis perbedaan nilai ekspresi 
CGRP, VIP, dan TNF-α tiap kelompok uji. Hasil: Injeksi PgLPS meningkatkan CGRP, VIP an TNF-α walau tidak 
selalu bermakna pada kelompok kontrol. Ekspresi CGRP dan TNF-α menurun, tetapi ekspresi VIP meningkat 
pada kelompok ADT. Simpulan: Peradangan neurogenik terlibat dalam penyebaran keradangan rongga mulut 
ke seluruh tubuh yang dimungkinkan karena ADT mengurangi peradangan organ lain melalui stimulasi VIP. 
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INTRODUCTION
Focal infection theory postulates that a myriad of 
diseases could be caused by microorganisms that arise 
endogenously from a focus of infection.1 In the 20th 
century, this concept was pioneered by William Hunter, 
in a publication and a 1910 talk at McGill University, 
Montreal. He said that dental restorations “built in, 
on, and around diseased teeth which form a veritable 
mausoleum of gold over a mass of sepsis to which 
there is no parallel in the whole realm of medicine.” 
It emphasized the importance of cooperation between 
dentists and physicians, as well as the necessity of 
ensuring that the focus of infection is completely 
eliminated.2 Since then, it became a common practice 
to extract all endodontically or periodontally involved 
teeth to eliminate focal infection. However, the concept 
was eventually forgotten by medical and dental society 
in the 30’s since there were no clear result.3
Interestingly, this theory is currently being carefully 
reconsidered. At the landmark conference at the 
University of North Carolina in 1997, it was devoted 
to this theme, that periodontal disease can contribute 
conditions such as cardiovascular the disease and 
that periodontal therapy may contribute to control 
of diabetes.2 Nevertheless, the concept of oro-
systemic connections mainly based on immunological 
mechanism. The effect of neurogenic mechanism that 
responsible to amplify immunogenic inflammation was 
rarely investigated. 
Moreover, immunological concept of oral focal 
infection could not explain the rapid improvement of 
asthma symptoms after periodontal treatment. The 
assisted drainage therapy (ADT), a new periodontal 
therapy, that is consisted of scaling root planing 
combined with subgingival massage. Previous studies 
have shown that ADT significantly improved forced 
expiratory volume in one second (FEV1) in allergic 
asthma children in Dr Soetomo Hospital Surabaya.4 
The asthmatic symptoms diminished within 5 minutes 
following ADT. The antiinflammation mechanism 
of ADT was still uncovered. One of the possibilities 
would be the involvement of neurogenic inflammation 
that give fast response after treatment. Oral neurogenic 
inflammation article was considered rare.5 Therefore, 
the progress of oral neurogenic research towards 
systemic diseases was slow. In medicine, there was a 
concept called “neurogenic switching” introduced by 
Meggs in 1997. It revealed the interaction between mast 
cells (MC) and sensory nerve.6 It proposed that distant 
inflammation may caused by the propagation or spread 
of this interaction. 
Inflammation is a critical process in the oral cavity, 
especially in gingival inf lammation and pulpitis. 
Nevertheless, the cellular process involved in oral 
inflammation is not well delineated. Recent evidence 
from other organs as well as the mouth suggests that 
neurogenic inflammation involving MCs may be a 
critical factor.7 Spreading of inflammation was caused 
by amplification of local inflammation via mast cell-
nerve interaction involving proinflammatory mediators 
calcitonin gene-related peptide (CGRP) which able 
to stimulate MCs whose product tumor necrosis 
factor-α (TNF-α) is able to stimulate nerve endings, 
thus became a “vicious circle”.6 In order to achieve 
homeostasis, which is the healthy stage of the body, 
naturally the body also releases antiinf lammatory 
mediator such as vasoactive intestinal peptide (VIP).8 
However, the role of VIP in mast cell-nerve interaction 
is not clearly understood. The objective of this study 
was to verify the spread of neurogenic inflammation 
in periodontal tissue to distant organ by examining 
nasal and bronchus tissue as well as ADT role in 
the downregulation of inflammation via stimulating 
antiinflammatory mediator release.
METHODS
This research was conducted in the Biology Department 
Brawijaya University Malang. The research protocol 
had been approved by the Animal Care and Use 
Ethical Committee, Faculty of Veterinary Medicine, 
Airlangga University, Surabaya. Intragingival injection 
PgLPS1435/1450 (Astarte Biologics, WA, USA) was 
performed on twenty four male wistar rats with weight 
ranging from 120-150 grams.9,10 One group of 12 rats 
subjected to 0.3 μg/mL (low dose), other group of 12 
rats subjected to 3.0 μg/mL (high dose), and six rats was 
injected with phosphate buffered saline (PBS) which 
served as control group. Exact dose of PgLPS1435/1450 
achieved by diluting 100 μg PgLPS1435/1450 with PBS. 
After four days of injection, 6 rats of each experimental 
group was treated with assisted drainage therapy (ADT) 
(Figure. 1). The assisted drainage therapy, a procedure 
of subgingival massage using the blunt side/back of 
sickle shaped scaler, was done for 3 minutes between 
the upper first and second molars. The rats in all groups 
were sacrificed 30-40 minutes after ADT. Nasal and 
bronchus tissue samples of were taken for analysis. 
Demineralization of the tissue samples was performed 
for 7-10 days with ethylenediaminetetraacetic acid 
(EDTA). The TNF-α (Santa Cruz Biotech, USA); (2) 
CGRP (Santa Cruz Biotech, USA); and (3) VIP (Santa 
Cruz Biotech, USA) monoclonal antibodies were 
used for peroxidase immunohistochemistry analysis 
according to the manufacturer instruction. Statistical 
analysis was done with Analysis of Variance (ANOVA) 
to analyse the interaction between TNF-α, CGRP and 
VIP as inflammation biomarkers with concentration of 
PgLPS1435/1450 doses and ADT. The number of cells with 
positive expression of neurogenic and immunogenic 
biomarkers on nasal and bronchus tissue samples were 
counted per view using light microscopy (Olympus™ 
CX-31).
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Table 1. Immunogenic and neurogenic inflammation in nose 
after PgLPS1435/1450 injection
Dependent 
variable
Control
Mean ± SD
PgLPS1435/1450
0.3 µg/mL
n = 6
p PgLPS1435/1450
3.0 µg/mL
n = 6
p
Immunogenic
TNF-α
Neurogenic
CGRP
VIP
5.00±0.89
1.83±0.98
2.67± 2.34
  29.83±1.17
   6.33±2.58
   3.67± 1.51
0.001
0.014
 0.773*
34.83±2.48
2.67±1.21
3.67±1.37
0.001
0.992*
0.077*
Table 2. Immunogenic and neurogenic inf lammation in 
bronchus after PgLPS1435/1450 injection
Dependent 
variable
Control
Mean±SD
PgLPS1435/1450
0.3 µg/mL
n = 6
p PgLPS1435/1450
3.0 µg/mL
n = 6
p
Immunogenic 
TNF-α
Neurogenic 
CGRP
VIP
10.00±2.76
2.33±1.86
1.33±0.82
20.33±3.01
11.50±1.38
5.00±1.26
0.001
0.001 
0.002
 
21.67±1.63
12.33±1.37
8.00±1.41
0.001 
0.001 
0.001 
Table 3. The effect of assisted drainage toward inflammations 
in nose
Before After ADT 
PgLPS1435/1450 
0.3 µg/mL  
n = 6
  p Before After ADT 
PgLPS1435/1450 
3.0 µg/mL 
n= 6
p
Immunogenic
TNF-α
Neurogenic 
CGRP
VIP
20.17±0.98
6.33±2.58
3.67± 1.51
15.00±2.28
   
7.50±4.23
  8.33±2.66
0.001
0.577*
0.004*
    
25.67± 3.20
  5.50±2.88
  6.00±1.26
20.33 ± 3.01 
   
2.33±1.37
8.83±3.12
0.014
0.035
0.067*
Figure 1. Assisted drainage therapy in Wistar rat Figure 2. Bronchus CGRP expression. After PgLPS1435/1450 
injection (day 4). Brown stain. Magnification: 400x
Table 4. The effect of assisted drainage towards inflammations 
in bronchus
Dependent 
variable
Before ADT        After AD
       PgLPS1435/1450  0.3 µg/mLn = 6
Before ADT        After ADT
    PgLPS1435/1450   3.0 µg/mL n = 6
Mean±SD Mean±SD p Mean±SD Mean±SD p
Immunogenic
TNF- α
Neurogenic 
CGRP
VIP
20.33±3.01
11.50±1.38
5.00±1.26
15.00±2.10
7.33±3.44 
12.33±1.86
0.005
  
0.020 
0.001
 
 21.67±1.63
 12.33±1.37
 8.00±1.41
16.33±1.03
8.67±1.97
23.00±1.79
0.001 
0.004 
0.001
RESULTS
The immunopositive staining of neurogenic and 
immunogenic biomarkers on nasal and bronchus 
tissue samples using were counted per view using 
the Olympus™ CX-31 light microscope. The CGRP 
expression in nasal and bronchus was shown in Figure 
2. This study showed that the effect of oral infection 
via PgLPS1435/1450 injection that disseminate to nose 
and bronchus resulted in increasing trend of pro-
inflammatory mediators expression, however the result 
was not always significant (Table 1 and Table 2).
In nose tissue, significant decrease of TNF-α expression 
was seen after performing ADT on PgLPS1435/1450 
injected rats (p=0.001 and p=0.014) and only slight 
decrease of CRGP expression was noted (p>0.05). On 
the other hand, VIP expression in nose tissue after ADT 
on low dose injected of PgLPS1435/1450 was significantly 
increased after ADT (p=0.004) (Table 3).
Performing ADT on the two experimental groups 
resulted in significant decrease of pro-inflammatory 
mediators (CGRP and TNF-α) in bronchus tissue. There 
were significant decrease on the number of cells with 
CGRP expression between low (p=0.002) and high 
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(p=0.004) dose of PgLPS1435/1450 injection in bronchus 
compared to control before and after ADT. While the 
CGRP expression decreased almost half of control 
after ADT, the TNF-α expression was only slightly 
decreased within the groups, however the results 
were still statistically significant (p=0.005 vs p=0.001 
respectively) (Table 4). On the contrary, the expression 
of VIP on bronchus tissue after ADT of PgLPS1435/1450 
injection showed two fold increase in the low dose 
group (p=0.001) and almost three fold increase in the 
high dose group (p=0.001) (Table 4). 
DISCUSSION
During the past decades the relationship between 
dentistry and internal medicine, especially the concept 
of focal infection theory has long been a debatable 
matter.11 The pathogenesis of focal diseases has been 
classically attributed to dental pulp pathologies and 
periapical infections.2 Nonetheless, in recent years, 
their roles are being dismissed, while increasing interest 
is being devoted to the possible association between 
periodontal infection and systemic diseases.3,12 In 
fact, periodontal pathogens and their products, as well 
as inflammatory mediators produced in periodontal 
tissues, might enter the bloodstream, causing systemic 
effects and/or contributing to systemic diseases. 
Chronic periodontitis has been suggested as a risk 
factor for cardiovascular diseases, diabetes mellitus, 
preterm delivery, etc.12 Many hypotheses, including 
common susceptibility, systemic inflammation, direct 
bacterial infection and cross-reactivity, or molecular 
mimicry, between bacterial antigens and self-antigens, 
have been postulated to explain the mechanism.12
Mast cells, best known for their role in allergic reactions, 
are also involved in immunity and inflammation. They 
are located at strategic point, that close to small blood 
vessels and nerve fibers and often containing substance 
P (SP) and CGRP.13 The pain models of reversible or 
irreversible pulpitis simply suggest the complexity of 
neural-inflammatory interactions within the dental 
pulp.7 Nevertheless, interestingly, in periodontal 
inflamation, chronic periodontitis does not elicit pain.14 
In the pulp and periapical area, neuropeptides and 
cytokines modulate vascular responses and increase 
permeability. Immunoreactive nerve fibers and TNF-
positive MCs were found localized around blood 
vessels in periapical granulomas.7 By generating a 
profound number of potent mediators, MCs may serve 
as a link between the immune, endocrine and nervous 
systems in pulp and periodontal inflammation.5
Mast cells and nerves interaction have been proven 
to be responsible for flare reaction to noxious stimuli, 
as seen in the skin. Local injury and/or antidromic 
stimulation of neurons sensitizes local C fibers which 
then release chemical mediators during the axon-
reflex. The local C fibers are SP, CGRP and other 
neuropeptides.7 Substance P has an important role 
in acute inf lammation, whereas CGRP in chronic 
inflammation.13 In this study, the effect of oral infection 
via PgLPS1435/1450 injection to distant organ (nose and 
bronchus) was described in Table 1 and Table 2. There 
was increased of proinflammatory mediators even 
not always significant. It was in accordance previous 
study that revealed that PgLPS was “weaker” than E. 
coli LPS, and organ-dependent.14 In that study, PgLPS 
only stimulated scalp but not heart, resulted a different 
biomarkers modulation from bronchus.
In patient with migraine and asthma, CGRP,15,16 VIP15 
and TNF-α16 were considered as valid diagnostic 
biomarkers. Therefore, recent drug findings were 
antagonists and inhibitors, such as CGRP-receptor 
antagonist for migraine17 and TNF-α inhibitor for 
asthma.18 However, drug-dependent have deleterious 
effect i.e. cardiovascular side effects (CGRP 
antagonist)17 and more for TNF-α inhibitor (heart 
failure, infections, neutropenia etc),18. Despite of the 
idea of drug-therapy, our interesting finding was a 
non-drug therapy which is the ADT. It has the ability to 
reduce migraine and asthma symptoms within minutes. 
In this animal study, after ADT there was significant 
decrease of pro-inf lammatory mediators both in 
low and high dose PgLPS injections in bronchus 
CGRP (p=0.020 and p=0.004) and TNF-α (p=0.005 
and p=0.001) expressions; concomitantly with the 
significant increase of antiinflammatory mediators 
in bronchus, that was VIP (p=0.001 and p=0.001) 
within minutes. Subsequently, euthanasia was done 30 
mins after ADT (Table 3 and Table 4). These results 
verified the rapid relief after ADT towards migraine 
and asthma. Decrease of pro-inflammatory mediators 
that accompanied by increasing of anti-inflammatory 
mediators should lead the body to homeostasis, thus 
cure the illness. 
It was interesting that in nasal tissue, the results of 
ADT towards neurogenic inflammation was not as 
remarkable as in bronchus tissue. Decrease of nasal 
CGRP were insignificant (p=0.577 and p=0.035). The 
non-significant decrease of CGRP may caused by the 
stimulated sensory CGRP- receptor in maxillary nerves 
after ADT, which is a mechanical massage therapy with 
manual scaler. It was in accordance with previous study 
which used several rotary endodontic instruments. 
The study reported that the severity of periodontal 
ligament inflammation was directly proportional to 
the degree the mechanical stress exerted on the tooth.19 
This mechanical stress then stimulates the release SP 
and CGRP.19 In our study, the increase of periodontal 
CGRP propagated to maxillary nerve in the nose which 
nearer to the mouth than bronchus. Thus, increase of 
CGRP expression in nasal tissue after ADT was logical.
The increase of VIP after ADT even it was a biomarker 
for migraine and sinusitis15 was not regarded as a 
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negative effect, owing to its anti-inflammatory effect 
by acting as macrophage-deactivating factors to 
prevent the excessive production of pro-inflammatory 
cytokines i.e. inhibits LPS-induced TNF-α, IL-6, and 
IL-12 production in activated macrophage.8 It was 
reported that VIP is a potent vasodilator of airway 
smooth muscle in vitro and in vivo.20 In isolated 
tracheal or bronchial segments, VIP attenuates the 
constrictor effect of histamine, leukotriene D4, 
kallikrein and neurokinin A. The bronchodilatory 
effect of VIP in human bronchi is almost 100 
times more potent than adrenergic dilatation by 
isoproterenol, and VIP is the most potent endogenous 
bronchodilator described so far. The problem was 
owing to very short half-life of 2 to 5 mins that makes 
difficult for application. However, it was invented 
intranasal VIP that was considered beneficial for 
correcting chronic inflammatory response syndrome 
(CIRS) which is a common illness nowadays.21 As 
the result, increasing VIP level is beneficial for 
maintaining systemic health.
The presence of MCs-nerve interaction was verified 
based on the simultaneous increase of both pro-
inflammatory biomarkers (CGRP and TNF-α) after 
injection which followed by simultaneous decrease after 
ADT. In this study, ADT stimulate anti-inflammatory 
mediators VIP. VIP was considered to have important 
role in rapid relief of ADT.
CONCLUSION
In conclusion, oral focal infection theory could be 
explained as an interaction of immunogenic and 
neurogenic inflammation from the oral tisssue that 
amplified and propagate to the whole body. The ADT 
is able to downregulate immunogenic and neurogenic 
inflammation by increasing VIP in distant organs, thus 
recreates homeostasis within minutes. However, further 
multidisciplinary research with medical researchers 
should be performed to give more understanding on 
the mechanism. 
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